Case closed: Neutrons settle 40-year debate on enzyme for drug design
Filter News
Area of Research
- (-) Computational Biology (1)
- Advanced Manufacturing (3)
- Biological Systems (1)
- Biology and Environment (78)
- Biology and Soft Matter (1)
- Clean Energy (51)
- Climate and Environmental Systems (1)
- Fusion and Fission (7)
- Materials (15)
- Materials for Computing (2)
- National Security (13)
- Neutron Science (11)
- Nuclear Science and Technology (4)
- Quantum information Science (1)
- Supercomputing (54)
News Type
Date
Media Contacts
An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus.